A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer
Clinical trial NCT05353361 · UNKNOWN
Trial details
- NCT number
- NCT05353361
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2025-12-31
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.